Testing no-meal alerts in automated insulin delivery systems
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at whether turning off meal announcements in automated insulin delivery systems (which adjust insulin automatically) is safe and effective for people with type 1 diabetes. It may help simplify daily diabetes management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and live in Canada or the United States.
- You have had type 1 diabetes for at least one year.
- You have been using an open-source automated insulin delivery system for at least 2 weeks and use a Dexcom G6 or G7 continuous glucose monitor.
- If you use ultra-rapid insulin, you are willing to switch to a rapid-acting insulin for the study.
- You agree to share your personal pump settings with the research team during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This trial tests a new experimental automated insulin delivery system (a type of 'artificial pancreas') to see if it is safe and works better than current systems. It may help people whose blood sugar is not well controlled with their current pump or system.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This trial tests MODI, a smartphone app that helps automatically adjust your insulin doses based on blood sugar readings from a continuous glucose monitor. The study checks if this system is safe and helps people with type 1 or type 2 diabetes manage their blood sugar better.
This study tests whether using an automated insulin delivery system (a smart pump that adjusts insulin based on sensor readings) can help improve blood sugar control and bone health in adults with Type 1 diabetes who have high and unstable blood sugars.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.